Swiss National Bank Veracyte, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Veracyte, Inc. stock. As of the latest transaction made, Swiss National Bank holds 149,300 shares of VCYT stock, worth $6.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

149,300

Previous 146,200 2.12%

Holding current value

$6.1 Million

Previous $3.17 Million 60.35%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$21.0 - $35.25 $65,100 - $109,275	3,100 Added 2.12%	149,300 $5.08 Million
Q2 2024 Aug 08, 2024	BUY	$18.86 - $23.55 $52,808 - $65,940	2,800 Added 1.95%	146,200 $3.17 Million
Q4 2023 Feb 06, 2024	SELL	$19.72 - $28.68 $311,576 - $453,144	-15,800 Reduced 9.92%	143,400 $3.94 Million
Q3 2023 Nov 08, 2023	BUY	$22.33 - $29.92 $46,893 - $62,832	2,100 Added 1.34%	159,200 $3.55 Million
Q2 2023 Aug 09, 2023	BUY	$20.96 - $26.99 $46,112 - $59,378	2,200 Added 1.42%	157,100 $4 Million
Q1 2023 May 10, 2023	SELL	$20.58 - $27.89 $370,439 - $502,020	-18,000 Reduced 10.41%	154,900 $3.45 Million
Q4 2022 Feb 08, 2023	BUY	$15.31 - $29.94 $53,585 - $104,790	3,500 Added 2.07%	172,900 $4.1 Million
Q3 2022 Nov 09, 2022	BUY	$16.58 - $27.9 $23,211 - $39,060	1,400 Added 0.83%	169,400 $2.81 Million
Q1 2022 May 09, 2022	BUY	$21.94 - $42.51 $267,668 - $518,622	12,200 Added 7.83%	168,000 $4.63 Million
Q4 2021 Feb 08, 2022	BUY	$36.09 - $53.79 $259,848 - $387,288	7,200 Added 4.85%	155,800 $6.42 Million
Q3 2021 Nov 08, 2021	BUY	$35.62 - $52.97 $32,057 - $47,673	900 Added 0.61%	148,600 $6.9 Million
Q2 2021 Aug 06, 2021	SELL	$32.94 - $56.62 $46,116 - $79,268	-1,400 Reduced 0.94%	147,700 $5.91 Million
Q1 2021 May 07, 2021	BUY	$44.47 - $81.38 $929,423 - $1.7 Million	20,900 Added 16.3%	149,100 $8.01 Million
Q3 2020 Nov 09, 2020	BUY	$26.73 - $35.67 $609,444 - $813,276	22,800 Added 21.63%	128,200 $4.17 Million
Q2 2020 Aug 05, 2020	BUY	$19.49 - $28.11 $300,146 - $432,894	15,400 Added 17.11%	105,400 $2.73 Million
Q1 2020 May 08, 2020	BUY	$16.13 - $30.17 $32,259 - $60,340	2,000 Added 2.27%	90,000 $2.19 Million
Q4 2019 Feb 06, 2020	BUY	$20.78 - $29.99 $361,572 - $521,826	17,400 Added 24.65%	88,000 $2.46 Million
Q3 2019 Nov 12, 2019	BUY	$23.87 - $30.93 $224,378 - $290,742	9,400 Added 15.36%	70,600 $1.69 Million
Q2 2019 Aug 02, 2019	BUY	$22.1 - $28.56 $1.35 Million - $1.75 Million	61,200 New	61,200 $1.75 Million

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.7M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.93B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Veracyte, Inc. Transaction History